Health & Wellness

UK allows mixing COVID-19 vaccines as experts warn of risks

Jorge Fitz-Gibbon
New York Post
Fri, 01 Jan 2021 06:55 UTC

British health officials will now allow people to mix COVID-19 vaccines as the pandemic rages on — but experts warn it could be risky.

The tweak in vaccine advice, which comes as the country grapples with a new, highly contagious mutation of the virus, marks a surprising departure from previous guidance — and a starkly different approach to the vaccine rollout in the US, The New York Times reported.

The UK protocol now states that a person can receive their follow-up COVID-19 jab with a different vaccine candidate to their first dose, if necessary. Britain has approved two vaccines for the deadly bug, developed by AstraZeneca and Pfizer. The updated guidance states:

"For individuals who started the schedule and who attend for vaccination at a site where the same vaccine is not available, or if the first product received is unknown, it is reasonable to offer one dose of the locally available product to complete the schedule."

However, the protocol does reiterate that receiving a second dose of the same vaccination is preferable, noting that a different inoculation should only be used if the patient is at "immediate high risk" or is considered "unlikely to attend again." "In these circumstances, as both the vaccines are based on the spike protein, it is likely the second dose will help to boost the response to the first dose," it explained.

But the new advice has still raised eyebrows in the scientific community.

Comment: Vaccine wars across the pond? Jabs abound:

"The New York Times really does have it in for poor old Britain, doesn't it? Not content with portraying Brits as boiled mutton eating swamp dwellers..."

HUNDREDS of Israelis get infected with Covid-19 after receiving Pfizer/BioNTech vaccine

RT
Fri, 01 Jan 2021 18:03 UTC

© Reuters / Amir Cohen
An ultra-Orthodox Jewish man receives a vaccination against the coronavirus disease in Ashdod, Israel.

With the vaccine not providing immediate immunity to the coronavirus, over two hundred Israeli citizens have been diagnosed with the disease days after getting the Pfizer/BioNTech jabs, local media reported.

The number of those who got Covid-19 despite being vaccinated was at around 240 people, according to data from Channel 13 News.

The Pfizer/BioNTech vaccine, which the Israeli health authorities rely on, doesn't contain the coronavirus and can't infect the recipient. But time is needed for the genetic code in the drug to train the immune system to recognize and attack the disease.

The course of the US-made vaccine requires two shots. According to the studies, immunity to Covid-19 increases only eight to ten days after the first injection and eventually reaches 50 percent.

Comment: The Gateway Pundit reports that over in the US numerous people have contracted coronavirus after receiving the vaccine:

As the highly touted Covid vaccine makes its way into the arms of nurses, doctors, elderly, and others who are immuno-compromised, it appears as though it isn't as effective as we were led to believe. An ER nurse in San Diego received his Covid vaccination last week. Seven days later, he started feeling symptoms, and tested positive for the virus the next day.

Cue the experts, who tell us this isn't uncommon, it's what they expect, and this is only one of many cases where a vaccinated individual still contracted the virus.

UPDATE: We're being told that all along doctors and Pfizer have said this is a two dose vaccine, and that the first dose could be ineffective. A second dose is necessary about 30 days later to acquire actual immunity. In the meantime, those who got the first dose are still susceptible to the virus.
In a Facebook message posted on December 18, Matthew W., an ER nurse at two different local hospitals, talked about receiving the Pfizer vaccine that day. He told ABC 10News his arm was sore for a day but he suffered no other side effects.

Six days later on Christmas Eve — after working a shift in the COVID-19 unit — Matthew, 45, became sick. He got the chills and later came down with muscle aches and fatigue.

The day after Christmas, he went to a drive-up hospital testing site and tested positive for COVID-19.

"It's not unexpected at all. If you work through the numbers, this is exactly what we'd expect to happen if someone was exposed," said Dr. Christian Ramers, an infectious disease specialist with Family Health Centers of San Diego. He serves on the clinical advisory panel for the county's vaccine rollout.

Dr. Ramers says he knows of several other local cases where health care workers became infected around the time they received the vaccine. He says all the cases illustrate the fact that results aren't immediate. Even after you start receiving some protection, it won't be full protection.

"That first dose we think gives you somewhere around 50%, and you need that second dose to get up to 95%," said Dr. Ramers.

COVID 'vaccines' are a medical experiment on humanity

Tricia Consaga
Dr.Tom Cowan.com
Thu, 31 Dec 2020 03:23 UTC

How are the COVID vaccines different from other vaccines on the market?

The COVID vaccines are mRNA (messenger RNA) vaccines, which are completely new. No mRNA vaccine has ever been licensed for human use before. There are no other therapies or prophylactics on the market that use the same approach, despite a handful of efforts.

Traditional vaccines introduce pieces of a virus ("live" or inert), as well as adjuvants such as aluminum and mercury, to stimulate an immune reaction. The new mRNA vaccine is completely different. It actually injects (transfects) molecules of synthetic genetic material from non-human sources into our cells. Once in the cells, the genetic material interacts with our transfer RNA (tRNA) to make a foreign protein that supposedly teaches the body to destroy the virus being coded for. So the vaccine is hijacking the protein-makeup machinery.

Note that these newly created proteins are not regulated by our own DNA, and are thus completely foreign to our cells. What they are fully capable of doing is unknown.

The Moderna vaccine is given in two doses, 28 days apart. The Pfizer vaccine will require two shots, three weeks apart.

The Pfizer and Moderna vaccines also include the traditional toxic adjuvants.

Actual science: University of Florida researchers find no asymptomatic or presymptomatic spread of Coronavirus

Len Cabrera
Rational Ground
Mon, 28 Dec 2020 18:54 UTC

University of Florida Department of Biostatistics

Four researchers from the University of Florida Department of Biostatistics co-authored a study published online by the Journal of the American Medical Association. They performed a meta-analysis of 54 studies looking at the household secondary attack rate of SARS-CoV-2. According to the CDC, the secondary attack rate is the number of new cases among contacts divided by the total number of contacts.

The researchers confirmed that SARS-CoV-2 is more contagious than other coronaviruses, with a secondary attack rate of 16.6% (95% CI 14.0%-19.3%) compared to 7.5% (95%CI 4.8%-10.7%) for SARS-CoV and 4.7% (95%CI, 0.9%-10.7%) for MERS-CoV.

Comment: See also:

Scientists scramble to identify culprit behind covid vaccine allergic reactions

Tyler Durden
ZeroHedge
Sat, 26 Dec 2020 14:00 UTC

Polyethylene glycol

All is not going according to plan in the global rollout of what is arguably the most important vaccine in a century, and it is not just growing mistrust in the covid injection effort that was rolled out in record time: an unexpected spike in allergic reactions to the Pfizer/BioNTech vaccine may prove catastrophic to widespread acceptance unless scientists can figure out what is causing it after the FDA's rushed approval. So in a welcome development, the WSJ reports that according to scientists, the potential culprit causing the allergic reactions to the Pfizer/BioNTech vaccine is the compound polyethylene glycol, also known as PEG.

According to the CDC, at least six severe allergic reactions to the vaccine have been reported so far in the US out of 272,001 doses administered through Dec. 19, while at least two cases of anaphylaxis have also occurred in the UK.

Polyethylene glycol - a polyether compound derived from petroleum with many applications, from industrial manufacturing to medicine - is present in both the Moderna and Pfizer-BioNTech vaccines for SARS-CoV-2 as a PEGylated lipid, which is used as an excipient. Both RNA vaccines consist of Messenger RNA, or mRNA, encased in a bubble of oily molecules called lipids. Proprietary lipid technology is used for each. In both vaccines, the bubbles are coated with a stabilizing molecule of polyethylene glycol.

Comment: See also:

Doctor reportedly has severe allergic reaction to Moderna COVID vaccine

Aaron Feis
New York Post
Sat, 26 Dec 2020 10:12 UTC

A Boston doctor suffered a serious allergic reaction to Moderna's coronavirus vaccine, the first of its kind documented, a report said Friday.

Dr. Hossein Sadrzadeh, a geriatric oncologist at Boston Medical Center, became dizzy and felt his heart racing minutes after receiving the vaccine on Thursday, he told The New York Times.

"It was the same anaphylactic reaction that I experience with shellfish," Dr. Sadrzadeh told the paper, noting that his tongue became numb, his blood pressure plummeted and he broke into a cold sweat.

Comment: See also:

A brilliant analysis of vaccination, by Richard Moskowitz, MD and homeopath

Jon Rappoport
nomorefakenews.com
Thu, 24 Dec 2020 08:35 UTC

In the age of COVID, vaccination looms large. As in mandatory. And of course, toxic.

I've already covered two new vaccine technologies, one of which has already been pushed forward, to "protect" people from a virus that has never been properly proven to exist.

DNA vaccines, aka gene therapy, permanently alter recipients' genetic makeup in unknown ways. RNA vaccines (Pfizer's and Moderna's, just approved for COVID) can cause auto-immune reactions — which means the body attacks itself. [1] [2]

In this piece, I want to take a look at a few fundamentals about vaccination. In particular, the claim that vaccines have done a fantastic job of reducing case numbers of diseases, and therefore all criticisms of these injections are irrelevant.

From his bio [3]: "Richard Moskowitz was born in 1938, and educated at Harvard (B.A.) and New York University (M.D.). After medical school he did 3 years of graduate study in Philosophy at the University of Colorado in Boulder on a U. S. Steel Fellowship."

EPM301: The synthetic & patented cannabis compound 'more potent than CBD & THC'

Javier Hasse
Forbes
Fri, 25 Dec 2020 10:36 UTC

© d JACK GUEZ/AFP via Getty Images
Raphael Mechoulam delivers a speech to participants at the CannaTech conference, an international summit for accelerating cannabis innovation, in the Israeli city of Tel Aviv on March 7, 2016. Mechoulam is a leading figure in the medical cannabis research and serves today as the chairperson of the CannaTech conference.

Professor Raphael Mechoulam, also known as the "father of cannabis research," revealed his latest discovery, cannabidiolic acid methyl ester (EPM301), only a few months ago. The introduction of this new, patented compound (synthetic, fully stable acid-based cannabinoid molecules) caused a wave of excitement around the future of medicinal cannabis.

The compound in question was presented to the world in partnership with EPM, a global biotechnology company based in the U.S. that aims to bridge the gap between the cannabis and pharmaceutical industries.

Comment: That sounds like a possibly ominous partnership.

During a recent, exclusive conversation, CEO Reshef Swisa and Dr. Mechoulam, shared the history of the journey behind this revolutionary process and its significance in evolving the use of CBD as a pharmaceutical drug.

Comment: There are numerous naturally occurring compounds in cannabis that act synergistically and are yet to be fully understood. It may be that isolating and synthesizing one compound could impact the holistic effect and may ultimately be detrimental:

Also check out SOTT radio's: The Health & Wellness Show: The Highs and Lows of Cannabis as Medicine

Did you know you have a second brain?

Mind Matters
Wed, 23 Dec 2020 00:00 UTC

Our guts operate on a quite separate nervous system. Learning more will help control gastrointestinal diseases

Our huge gastrointestinal tracts operate their own nervous system, using neurons that follow different principles from those of brain neurons, according to recent findings:

Our approximately seven-meter long gastrointestinal (GI) tract has its own functionally distinct neurons. Since this enteric nervous system (ENS) operates autonomously, it is sometimes referred to as the "second" or "abdominal" brain. While the ENS controls muscle movement (peristalsis) in the gut and its fluid balance and blood flow, it also communicates with the immune system and microbiome.

Karolinska Institutet, "New fundamental knowledge of the 'abdominal brain'" at Medical Xpress (December 7, 2020) Paper.

Comment: See also:

New class of antibiotics active against a wide range of bacteria discovered

The Wistar Institute
Source
Wed, 23 Dec 2020 12:00 UTC

Wistar Institute scientists have discovered a new class of compounds that uniquely combine direct antibiotic killing of pan drug-resistant bacterial pathogens with a simultaneous rapid immune response for combatting antimicrobial resistance (AMR). These finding were published today in Nature.

The World Health Organization (WHO) has declared AMR as one of the top 10 global public health threats against humanity. It is estimated that by 2050, antibiotic-resistant infections could claim 10 million lives each year and impose a cumulative $100 trillion burden on the global economy. The list of bacteria that are becoming resistant to treatment with all available antibiotic options is growing and few new drugs are in the pipeline, creating a pressing need for new classes of antibiotics to prevent public health crises.

"We took a creative, double-pronged strategy to develop new molecules that can kill difficult-to-treat infections while enhancing the natural host immune response," said Farokh Dotiwala, M.B.B.S., Ph.D., assistant professor in the Vaccine & Immunotherapy Center and lead author of the effort to identify a new generation of antimicrobials named dual-acting immuno-antibiotics (DAIAs).

Comment: See also:

And check out SOTT radio's: The Truth Perspective: Are Cells the Intelligent Designers? Why Creationists and Darwinists Are Both Wrong